Clearstream Banking handling of medicinal cannabis related securities
Clearstream Banking1 informs customers that following the adoption of the Projet de Loi 7253 by the Chambre des Députés of Luxembourg on 28 June 2018, the restrictions outlined in Announcement A18095 will not be applied to securities where the main business consists of medicinal cannabis.
Clearstream Banking is currently updating the list of identified securities contained in A18095.
For further information, customers may contact Clearstream Banking Client Services or their Relationship Officer.
1. Clearstream Banking refers collectively to Clearstream Banking S.A., registered office at 42, avenue John F. Kennedy, L-1855 Luxembourg, and registered with the Luxembourg Trade and Companies Register under number B-9248, and Clearstream Banking AG (for Clearstream Banking AG customers using Creation Accounts), registered office at 61, Mergenthalerallee, 65760 Eschborn, Germany and registered in Register B of the Amtsgericht Frankfurt am Main, Germany under number HRB 7500.